Russell Jones

Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial

Anthony Barnett, Ambrish Mithal, Jenny Manassie et al. · The Lancet Diabetes & Endocrinology · 2014 · 575 citations

Medicine, Pharmacology, Pharmacotherapy +14

Global Climate Change and Sea Level Rise: Potential Losses of Intertidal Habitat for Shorebirds

Hector Galbraith, Russell Jones, R. Park et al. · Waterbirds · 2002 · 386 citations

Life Sciences, Conservation Biology, Ecology +17

Empagliflozin improves glycaemic and weight control as add‐on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24‐week, randomized, placebo‐controlled trial

Christopher S. Kovács, V Seshiah, Ros Swallow et al. · Diabetes Obesity and Metabolism · 2013 · 383 citations

Medicine, Pharmacology, Pharmacotherapy +17

Climate change risks to US infrastructure: impacts on roads, bridges, coastal development, and urban drainage

James E. Neumann, Jason C. Price, Paul Chinowsky et al. · Climatic Change · 2014 · 205 citations · Full text

Planning, Infrastructure Planning, Infrastructure Policy +16

Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial

Anthony Barnett, Holger Huisman, Russell Jones et al. · The Lancet · 2013 · 181 citations

Medicine, Endocrinology, Pharmacology +14